Maria P.A. van Berkel

Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells

Monique C.A. Duyndam, Maria P.A. van Berkel, Josephine C. Dorsman et al. · Biochemical Pharmacology · 2007 · 77 citations

Medicine, Cancer Biology, Oncology +14

CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells

Dennis Fontijn, Monique C.A. Duyndam, Maria P.A. van Berkel et al. · British Journal of Cancer · 2006 · 39 citations · Full text

Medicine, Cell Biology, Oncology +11

Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

Marcel N.A. Bijman, Cristian A. Hermelink, Maria P.A. van Berkel et al. · Biochemical Pharmacology · 2007 · 37 citations

Medicine, Oncology, Pharmacology +11

Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines

Marcel N.A. Bijman, Maria P.A. van Berkel, Mirjam Kok et al. · Anti-Cancer Drugs · 2009 · 31 citations

Medicine, Oncology, Pharmacology +17

Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility

Marcel N.A. Bijman, Maria P.A. van Berkel, Geerten P. van Nieuw Amerongen et al. · Biochemical Pharmacology · 2008 · 23 citations

Life Sciences, Cell Biology, Oncology +16